Home/Filings/4/0001213900-20-004978
4//SEC Filing

Kaplan Myron 4

Accession 0001213900-20-004978

CIK 0001410098other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 9:46 PM ET

Size

12.3 KB

Accession

0001213900-20-004978

Insider Transaction Report

Form 4
Period: 2020-02-25
Kaplan Myron
Director
Transactions
  • Award

    Stock Option (Right to Buy Common Stock)

    2020-02-25$5.63/sh+15,000$84,45015,000 total
    Exercise: $5.63Exp: 2030-02-25Common Stock (15,000 underlying)
Holdings
  • Stock Option (Right to Buy Common Stock)

    Exercise: $8.30Exp: 2029-01-10Common Stock (15,000 underlying)
    15,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $2.85Exp: 2028-02-16Common Stock (8,000 underlying)
    8,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $21.40Exp: 2026-04-28Common Stock (10,000 underlying)
    10,000
  • Common Stock

    109,734
  • Stock Option (Right to Buy Common Stock)

    Exercise: $11.20Exp: 2027-02-21Common Stock (8,000 underlying)
    8,000
Footnotes (5)
  • [F1]These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
  • [F2]These options were granted on 01/10/2019. These options are fully vested.
  • [F3]These options were granted on 02/16/2018. These options are fully vested.
  • [F4]These options were granted on 02/21/2017. These options are fully vested.
  • [F5]These options were granted on 4/28/2016. These options are fully vested.

Issuer

CorMedix Inc.

CIK 0001410098

Entity typeother

Related Parties

1
  • filerCIK 0001672645

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 9:46 PM ET
Size
12.3 KB